Related Experiment Video
Updated: May 17, 2026
06:32
Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
Published on: May 2, 2025
Sampling conditions influence multiple electrode platelet aggregometry in cardiac surgery patients.
Martin Karlsson1, Christine Roman-Emanuel, Linda Thimour-Bergström
1Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden. martin.karlsson@vgregion.se
Scandinavian Cardiovascular Journal : SCJ
|October 27, 2012
Summary
Blood sampling conditions significantly impact multiple electrode platelet aggregometry (MEA) results in cardiac surgery patients. Avoid comparing MEA data collected with different anticoagulants, as sampling site and surgery affect platelet function.
Area of Science:
- Cardiovascular Surgery
- Hematology
- Clinical Pathology
Background:
- Platelet function testing is crucial for managing cardiac surgery patients.
- Multiple electrode platelet aggregometry (MEA) is increasingly used, but pre-analytical variables require standardization.
Purpose of the Study:
- To evaluate the influence of blood sampling conditions on MEA results in patients undergoing coronary artery bypass grafting (CABG).
- To assess the impact of anticoagulant type, blood sampling site, and surgical intervention on platelet aggregability.
Main Methods:
- Prospective observational study involving 81 first-time CABG patients.
- MEA analysis of platelet aggregability using adenosine-diphosphate (ADP) and thrombin-activating peptide 6 (TRAP).
- Comparison of hirudin vs. citrate anticoagulants, different blood sampling sites (peripheral vein, central venous catheter, radial artery), and pre- vs. postoperative samples.
Main Results:
- Platelet aggregability was 30% higher in hirudin tubes compared to citrate tubes.
- Significant correlation between hirudin and citrate tubes for TRAP-induced aggregability (r=0.84), but not for ADP-induced.
- Blood sampling site did not affect MEA results.
- Surgery significantly reduced both ADP-induced (31%) and TRAP-induced (30%) platelet aggregability.
Conclusions:
- MEA results are not comparable between samples collected with different anticoagulants (hirudin and citrate).
- Blood sampling site does not influence MEA outcomes.
- Cardiac surgery markedly reduces overall platelet aggregability, with significant intraindividual variability.
